The reasons underlying the immunogenicity [22] of melanoma cells are unclear and depend on molecular events that enhance their proliferation and expansion within the tumor microenvironment in the presence of inhibitory signals by interleukin (IL)-6, IL-10 and TILs, namely the tumor infiltrating lymphocytes. The gene discussed is IL6; the disease is melanoma.